The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
According to the National Institutes of Health, more than six million Americans, most age 65 or older, may have dementia caused by Alzheimer's disease, a brain disorder known to slowly destroy memory and thinking skills
With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods
The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making
Breakthrough formulation helps reduce the risk of exposure using a non-hazardous formulation and leakproof format during transport and processing
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
This has further strengthened its manufacturing presence in the United States of America
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
